000 01111 a2200313 4500
005 20250516223542.0
264 0 _c20141020
008 201410s 0 0 eng d
022 _a1365-2036
024 7 _a10.1111/apt.12847
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHvid-Jensen, F
245 0 0 _aLetter: proton pump inhibitors, GERD and oesophageal adenocarcinoma - authors' reply.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_cAug 2014
300 _a320 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAdenocarcinoma
_xprevention & control
650 0 4 _aBarrett Esophagus
_xdrug therapy
650 0 4 _aEsophageal Neoplasms
_xprevention & control
650 0 4 _aEsophagus
_xpathology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProton Pump Inhibitors
_xtherapeutic use
700 1 _aFunch-Jensen, P
700 1 _aDrewes, A M
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 40
_gno. 3
_gp. 320
856 4 0 _uhttps://doi.org/10.1111/apt.12847
_zAvailable from publisher's website
999 _c24022508
_d24022508